WXT declines, for the 16th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The archive — 2026
Page 33 of 34 of this archive, newest first.
Spain health authority warns on falsified exenatide pens
Reported from the analysis, not from a warning notice.
South Korea caps tirzepatide prescribing to 24 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Calibrated, qualified, accredited: three words that are not synonyms
System suitability is the set of checks demonstrating that the instrument and method were performing adequately when your sample was injected. It is recorded as a matter of…
A shortage listing ends. 7 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
What a 23% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
Inspectors cite the online reseller trading as Adamant Research Supply over sterility assurance
The observation that closes a facility is rarely the dramatic one.
What SURMOUNT-1 tells us about maintenance, and what it does not
Every withdrawal trial compared full dose against nothing. The clinically interesting comparison — full dose against a reduced one — has not been randomised.
What changed after we published the first version of this
None of what this piece asks for is commercially sensitive, and all of it is already known to whoever released the batch.
SURPASS-4 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Independent analysis puts a SSA semaglutide lot at 97.6%, against 94.1% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
The quiet end of the consolidator trading as Meridian Freight Partners
A proper account of an operation that existed, and of what closing it cost.
Leucine, isoleucine, and a difference no balance can measure
Stereochemical inversion changes the molecule, changes its biology, and changes its mass by exactly nothing.
Reading the retatrutide composition data without the press release
The trials measured mass. Nobody measured whether the participants got weaker.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What a 40% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
Spain pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
What the trials monitored, and what that implies about routine practice
Every additional analyte raises the probability of a flagged result and lowers the average information content of the panel.
Date of analysis, date of manufacture, and the gap between them
A document is only as good as the chain that connects it to the material, and most chains here are two or three links longer than the paperwork admits.
Spain health authority warns on falsified dulaglutide pens
Reported from the analysis, not from a warning notice.
SURMOUNT-OSA misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
What the new Poland guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Inspectors cite the relabeller trading as Vantris Bio over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The one randomised trial that combined an incretin with supervised exercise
Mass and function are different endpoints and training affects them differently. Most coverage treats them as one.
Holding a dose is a decision, not a failure
A dose held long enough stops being a pause and becomes a maintenance decision. That transition is rarely made explicitly.
What twenty companies say about storage, and what they have measured
What would make a difference is not a regulator. It is three lines on a certificate, all of which are already known to whoever wrote it.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
A supplier suspends shipping to Canada after 9 consecutive customs detentions
The route did not close because of a rule about peptides.